Pages

▼
Tuesday, November 19, 2024

Encellin Starts a Phase-I Trial of ENC-201-CED (Encapsulated Beta Cells)

›
The company Encellin has started a Phase-I clinical trial to test ENC-201-CED an encapsulated beta cell product. Encapsulated Beta Cells In ...
Friday, November 8, 2024

Frexalimab Starts A Phase-IIΔ Clinical Trial (FABULINUS)

›
There are two good reasons to test Frexalimab as a cure or treatment for Type-1 Diabetes (T1D).  The first is that it has shown some effecti...
Sunday, October 6, 2024

The full story on "Stem cells reverse woman’s diabetes — a world first"

›
If you've been reading news recently you might have seen headlines like these: Stem cells reverse woman’s diabetes — a world first Stem ...
Sunday, August 18, 2024

Combo of Rituximab and Abatacept Starts a Phase-II In Honeymooners (T1D RELAY)

›
Rituximab is FDA-approved to treat several autoimmune diseases, including Rheumatoid Arthritis (RA).  About 10 years ago there were a coupl...
1 comment:
Tuesday, July 16, 2024

Abrocitinib and Ritlecitinib Start A Phase-IIΔ Clinical Trail in Honeymooners (JAKPOT)

›
(Note: JAKPOT is a name of at least two different clinical trials.  If you are reading about a French clinical trial targeting Rheumatoid Ar...
Tuesday, June 4, 2024

BMF-219 Starts a Phase-IIΔ

›
BMF-219 is a drug that inhibits  Menin , a protein.  Menin's functions in cells are not fully understood, and may be complex and contrad...
Wednesday, May 1, 2024

Fenofibrate Starts A Phase-IIΔ Trial

›
Fenofibrate (also spelled Phenofibrate) is commonly prescribed for high cholesterol and high triglycerides. In 2017, it was the 70th most ...